Results 111 to 120 of about 1,464 (122)

HPIV3/deltaF-HN/EboGP

Drug Data Report, 2009
openaire   +1 more source

Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor

Journal of the American Chemical Society, 2020
VÍCTOR K Outlaw, Yun Zhu, Samuel H Gellman   +2 more
exaly  

Faculty Opinions recommendation of Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2005
openaire   +1 more source

Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers

Vaccine, 2006
Clare L Cutland, Ruth A Karron, William C Gruber   +2 more
exaly  

Antiviral siRNA multiplex treatment reduces HPIV3 infection and modulates inflammation in human precision-cut lung slices.

Respiratory infections and bronchiectasis
Anna Zimmer, Philippe Vollmer Barbosa, Fabian Röpken, Franziska Dahlmann, Sewald Katherina, Hook Sebastian, Ott Michael, Adrian Schwarzer, Axel Schambach, Armin Braun   +9 more
openaire   +1 more source

Inhibition of human parainfluenza virus type 3 infection by novel small molecules

Antiviral Research, 2008
Robert H Silverman, Andrei V Gudkov, Amiya K Banerjee   +2 more
exaly  

BPS2026 – Induction of host membrane curvature by the HPIV3 fusion peptide reveals a mechanical role in pre-fusion membrane destabilization

Biophysical Journal
Melanie A. Brunet, Laura J.S. Lopes, Wenjing Cheng, Tara Marcink, Myriam Cotten, Anne Moscona, Alexander J. Sodt, Joshua Zimmerberg   +7 more
openaire   +1 more source

Terminal sialic acid linkages determine different cell infectivities of human parainfluenza virus type 1 and type 3

Virology, 2014
Keijo Fukushima, Tadanobu Takahashi, Maiko Takano   +2 more
exaly  

Genetic analyses of the fusion protein genes in human parainfluenza virus types 1 and 3 among patients with acute respiratory infections in Eastern Japan from 2011 to 2015

Journal of Medical Microbiology, 2017
Hiroyuki Tsukagoshi, Koo Nagasawa, Masaki Takahashi   +2 more
exaly  

Development of a vaccine against hRSV and hPIV3 using a replication deficient Sendai virus vector.

2005
Gori Savellini G, S. Bossow, M Wiegand, Neubert Wj, G Di Genova, C Terrosi, MG Cusi.   +6 more
openaire   +1 more source